Global Depressive Disorder Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 115 pages | ID: G35326DEBE5GEN
GlobalInfoResearch

Abstracts

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.

SCOPE OF THE REPORT:

The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
The global Depressive Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Depressive Disorder.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Depressive Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Depressive Disorder market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Alkermes
• Allergan
• Bristol Myers Squibb
• Eli Lilly
• Glaxosmithkline
• H. Lundbeck
• Merck
• Pfizer
• Teva Pharmaceutical
• Takeda Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist And Reuptake Inhibitors
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Homecare Settings
• Long Term Care Centers

Contents

1 DEPRESSIVE DISORDER MARKET OVERVIEW

1.1 Product Overview and Scope of Depressive Disorder
1.2 Classification of Depressive Disorder by Types
  1.2.1 Global Depressive Disorder Revenue Comparison by Types (2017-2023)
  1.2.2 Global Depressive Disorder Revenue Market Share by Types in 2017
  1.2.3 Tricyclic Antidepressants
  1.2.4 Selective Serotonin Reuptake Inhibitors
  1.2.5 Serotonin-Norepinephrine Reuptake Inhibitors
  1.2.6 Monoamine Oxidase Inhibitors
  1.2.7 Serotonin Antagonist And Reuptake Inhibitors
  1.2.8 Others
1.3 Global Depressive Disorder Market by Application
  1.3.1 Global Depressive Disorder Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Diagnostic Centers
  1.3.5 Homecare Settings
  1.3.6 Long Term Care Centers
1.4 Global Depressive Disorder Market by Regions
  1.4.1 Global Depressive Disorder Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Depressive Disorder Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Depressive Disorder Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Depressive Disorder Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Depressive Disorder Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Depressive Disorder Status and Prospect (2013-2023)
1.5 Global Market Size of Depressive Disorder (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Alkermes
  2.1.1 Business Overview
  2.1.2 Depressive Disorder Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Alkermes Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
  2.2.1 Business Overview
  2.2.2 Depressive Disorder Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Allergan Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol Myers Squibb
  2.3.1 Business Overview
  2.3.2 Depressive Disorder Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bristol Myers Squibb Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
  2.4.1 Business Overview
  2.4.2 Depressive Disorder Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Eli Lilly Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.5 Glaxosmithkline
  2.5.1 Business Overview
  2.5.2 Depressive Disorder Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Glaxosmithkline Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.6 H. Lundbeck
  2.6.1 Business Overview
  2.6.2 Depressive Disorder Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 H. Lundbeck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Depressive Disorder Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
  2.8.1 Business Overview
  2.8.2 Depressive Disorder Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Pfizer Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical
  2.9.1 Business Overview
  2.9.2 Depressive Disorder Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Teva Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takeda Pharmaceutical
  2.10.1 Business Overview
  2.10.2 Depressive Disorder Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Takeda Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL DEPRESSIVE DISORDER MARKET COMPETITION, BY PLAYERS

3.1 Global Depressive Disorder Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Depressive Disorder Players Market Share
  3.2.2 Top 10 Depressive Disorder Players Market Share
3.3 Market Competition Trend

4 GLOBAL DEPRESSIVE DISORDER MARKET SIZE BY REGIONS

4.1 Global Depressive Disorder Revenue and Market Share by Regions
4.2 North America Depressive Disorder Revenue and Growth Rate (2013-2018)
4.3 Europe Depressive Disorder Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Depressive Disorder Revenue and Growth Rate (2013-2018)
4.5 South America Depressive Disorder Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Depressive Disorder Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA DEPRESSIVE DISORDER REVENUE BY COUNTRIES

5.1 North America Depressive Disorder Revenue by Countries (2013-2018)
5.2 USA Depressive Disorder Revenue and Growth Rate (2013-2018)
5.3 Canada Depressive Disorder Revenue and Growth Rate (2013-2018)
5.4 Mexico Depressive Disorder Revenue and Growth Rate (2013-2018)

6 EUROPE DEPRESSIVE DISORDER REVENUE BY COUNTRIES

6.1 Europe Depressive Disorder Revenue by Countries (2013-2018)
6.2 Germany Depressive Disorder Revenue and Growth Rate (2013-2018)
6.3 UK Depressive Disorder Revenue and Growth Rate (2013-2018)
6.4 France Depressive Disorder Revenue and Growth Rate (2013-2018)
6.5 Russia Depressive Disorder Revenue and Growth Rate (2013-2018)
6.6 Italy Depressive Disorder Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC DEPRESSIVE DISORDER REVENUE BY COUNTRIES

7.1 Asia-Pacific Depressive Disorder Revenue by Countries (2013-2018)
7.2 China Depressive Disorder Revenue and Growth Rate (2013-2018)
7.3 Japan Depressive Disorder Revenue and Growth Rate (2013-2018)
7.4 Korea Depressive Disorder Revenue and Growth Rate (2013-2018)
7.5 India Depressive Disorder Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Depressive Disorder Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA DEPRESSIVE DISORDER REVENUE BY COUNTRIES

8.1 South America Depressive Disorder Revenue by Countries (2013-2018)
8.2 Brazil Depressive Disorder Revenue and Growth Rate (2013-2018)
8.3 Argentina Depressive Disorder Revenue and Growth Rate (2013-2018)
8.4 Colombia Depressive Disorder Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE DEPRESSIVE DISORDER BY COUNTRIES

9.1 Middle East and Africa Depressive Disorder Revenue by Countries (2013-2018)
9.2 Saudi Arabia Depressive Disorder Revenue and Growth Rate (2013-2018)
9.3 UAE Depressive Disorder Revenue and Growth Rate (2013-2018)
9.4 Egypt Depressive Disorder Revenue and Growth Rate (2013-2018)
9.5 Nigeria Depressive Disorder Revenue and Growth Rate (2013-2018)
9.6 South Africa Depressive Disorder Revenue and Growth Rate (2013-2018)

10 GLOBAL DEPRESSIVE DISORDER MARKET SEGMENT BY TYPE

10.1 Global Depressive Disorder Revenue and Market Share by Type (2013-2018)
10.2 Global Depressive Disorder Market Forecast by Type (2018-2023)
10.3 Tricyclic Antidepressants Revenue Growth Rate (2013-2023)
10.4 Selective Serotonin Reuptake Inhibitors Revenue Growth Rate (2013-2023)
10.5 Serotonin-Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2023)
10.6 Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2023)
10.7 Serotonin Antagonist And Reuptake Inhibitors Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)

11 GLOBAL DEPRESSIVE DISORDER MARKET SEGMENT BY APPLICATION

11.1 Global Depressive Disorder Revenue Market Share by Application (2013-2018)
11.2 Depressive Disorder Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Homecare Settings Revenue Growth (2013-2018)
11.7 Long Term Care Centers Revenue Growth (2013-2018)

12 GLOBAL DEPRESSIVE DISORDER MARKET SIZE FORECAST (2018-2023)

12.1 Global Depressive Disorder Market Size Forecast (2018-2023)
12.2 Global Depressive Disorder Market Forecast by Regions (2018-2023)
12.3 North America Depressive Disorder Revenue Market Forecast (2018-2023)
12.4 Europe Depressive Disorder Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Depressive Disorder Revenue Market Forecast (2018-2023)
12.6 South America Depressive Disorder Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Depressive Disorder Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Depressive Disorder Picture
Table Product Specifications of Depressive Disorder
Table Global Depressive Disorder and Revenue (Million USD) Market Split by Product Type
Figure Global Depressive Disorder Revenue Market Share by Types in 2017
Figure Tricyclic Antidepressants Picture
Figure Selective Serotonin Reuptake Inhibitors Picture
Figure Serotonin-Norepinephrine Reuptake Inhibitors Picture
Figure Monoamine Oxidase Inhibitors Picture
Figure Serotonin Antagonist And Reuptake Inhibitors Picture
Figure Others Picture
Table Global Depressive Disorder Revenue (Million USD) by Application (2013-2023)
Figure Depressive Disorder Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Figure Homecare Settings Picture
Figure Long Term Care Centers Picture
Table Global Market Depressive Disorder Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Depressive Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Depressive Disorder Type and Applications
Table Alkermes Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Depressive Disorder Type and Applications
Table Allergan Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Depressive Disorder Type and Applications
Table Bristol Myers Squibb Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Depressive Disorder Type and Applications
Table Eli Lilly Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Depressive Disorder Type and Applications
Table Glaxosmithkline Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table H. Lundbeck Depressive Disorder Type and Applications
Table H. Lundbeck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Depressive Disorder Type and Applications
Table Merck Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Depressive Disorder Type and Applications
Table Pfizer Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Depressive Disorder Type and Applications
Table Teva Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Depressive Disorder Type and Applications
Table Takeda Pharmaceutical Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Global Depressive Disorder Revenue (Million USD) by Players (2013-2018)
Table Global Depressive Disorder Revenue Share by Players (2013-2018)
Figure Global Depressive Disorder Revenue Share by Players in 2016
Figure Global Depressive Disorder Revenue Share by Players in 2017
Figure Global Top 5 Players Depressive Disorder Revenue Market Share in 2017
Figure Global Top 10 Players Depressive Disorder Revenue Market Share in 2017
Figure Global Depressive Disorder Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Depressive Disorder Revenue (Million USD) by Regions (2013-2018)
Table Global Depressive Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Depressive Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Depressive Disorder Revenue Market Share by Regions in 2017
Figure North America Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Europe Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure South America Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Depressive Disorder Revenue and Growth Rate (2013-2018)
Table North America Depressive Disorder Revenue by Countries (2013-2018)
Table North America Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Depressive Disorder Revenue Market Share by Countries in 2017
Figure USA Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Canada Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Mexico Depressive Disorder Revenue and Growth Rate (2013-2018)
Table Europe Depressive Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Europe Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure Europe Depressive Disorder Revenue Market Share by Countries in 2017
Figure Germany Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure UK Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure France Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Russia Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Italy Depressive Disorder Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Depressive Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Depressive Disorder Revenue Market Share by Countries in 2017
Figure China Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Japan Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Korea Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure India Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Depressive Disorder Revenue and Growth Rate (2013-2018)
Table South America Depressive Disorder Revenue by Countries (2013-2018)
Table South America Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Depressive Disorder Revenue Market Share by Countries in 2017
Figure Brazil Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Argentina Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Colombia Depressive Disorder Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Depressive Disorder Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Depressive Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Depressive Disorder Revenue Market Share by Countries in 2017
Figure Saudi Arabia Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure UAE Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Egypt Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure Nigeria Depressive Disorder Revenue and Growth Rate (2013-2018)
Figure South Africa Depressive Disorder Revenue and Growth Rate (2013-2018)
Table Global Depressive Disorder Revenue (Million USD) by Type (2013-2018)
Table Global Depressive Disorder Revenue Share by Type (2013-2018)
Figure Global Depressive Disorder Revenue Share by Type (2013-2018)
Figure Global Depressive Disorder Revenue Share by Type in 2017
Table Global Depressive Disorder Revenue Forecast by Type (2018-2023)
Figure Global Depressive Disorder Market Share Forecast by Type (2018-2023)
Figure Global Tricyclic Antidepressants Revenue Growth Rate (2013-2018)
Figure Global Selective Serotonin Reuptake Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Serotonin-Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Serotonin Antagonist And Reuptake Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Depressive Disorder Revenue by Application (2013-2018)
Table Global Depressive Disorder Revenue Share by Application (2013-2018)
Figure Global Depressive Disorder Revenue Share by Application (2013-2018)
Figure Global Depressive Disorder Revenue Share by Application in 2017
Table Global Depressive Disorder Revenue Forecast by Application (2018-2023)
Figure Global Depressive Disorder Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Homecare Settings Revenue Growth Rate (2013-2018)
Figure Global Long Term Care Centers Revenue Growth Rate (2013-2018)
Figure Global Depressive Disorder Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Depressive Disorder Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Depressive Disorder Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Depressive Disorder Revenue Market Forecast (2018-2023)
Figure Europe Depressive Disorder Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Depressive Disorder Revenue Market Forecast (2018-2023)
Figure South America Depressive Disorder Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Depressive Disorder Revenue Market Forecast (2018-2023)